Under construction – not a live service
Sign in
Taking people in Hong KongNo phase

Tests a robotic system for removing bladder tumours in adults with bladder cancer

Tests a robotic system for removing bladder tumours in adults with bladder cancer.

Plain-language title generated from the registry record
Registry title: Performance, Feasibility, and Safety Study for a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours: First-In-Human Trial

Key facts

Where
Shatin, Hong KongSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT06281080, who can take part

Where in Hong Kong

  • Prince of Wales HospitalShatin, Hong KongTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Chinese University of Hong Kong
Trial code
NCT06281080
Record updated
3 November 2026
Original description
This is a prospective, single-arm study to evaluate the feasibility and safety of performing transurethral en-bloc resection of bladder tumours using the Zenith robotic system.Read full original descriptionShow less

First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours

This is a prospective, single-arm study to evaluate the feasibility and safety of performing transurethral en-bloc resection of bladder tumours using the Zenith robotic system.

Inclusion: Age between 18 and 75 years; Body mass index <35 kg/m2; Bladder tumour located <3 cm in size; clinically non-muscle invasive bladder tumour; Clinically indicated for en-bloc resection; Willingness to participate as demonstrated by giving informed consent.

Exclusion: Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention; Emergency surgery; Untreated active infection; Presence of another malignancy or distant metastasis; Presence of endoscopic or imaging signs of detrusor muscle invasion; Contraindication to general anaesthesia / spinal anaesthesia; ASA > 2 patients; Un-corrected coagulopathy; Vulnerable population (e.g. mentally disabled, pregnant).

ClinicalTrials.gov NCT06281080